Buy- & Sell-side Advisory
We have proven track record in advising companies from Biopharma and MedTech industries as well as financial investors such as Private Equity groups.
One of our highlight deals was the acquisition of Partec, Germany's leading flow cytometry specialist, by Sysmex Corporation Japan. BGM Associates advised the owners of Partec in conducting comprehensive strategic due diligence and preparing the organization for the transaction. We assisted the Partec team to find the most optimal strategic partner and finalize the deal. Partec's subsequent double digit sales growth following the integration with Sysmex reflected the perfect strategic fit of the two companies.
Partec - Sysmex transaction was selected as one of the best deals by transkript magazine. Read transkript's article here: Full article (pp. 5 - 6)
Our value contributions to Buy- and & Sell-side Advisory includes:
One of our highlight deals was the acquisition of Partec, Germany's leading flow cytometry specialist, by Sysmex Corporation Japan. BGM Associates advised the owners of Partec in conducting comprehensive strategic due diligence and preparing the organization for the transaction. We assisted the Partec team to find the most optimal strategic partner and finalize the deal. Partec's subsequent double digit sales growth following the integration with Sysmex reflected the perfect strategic fit of the two companies.
Partec - Sysmex transaction was selected as one of the best deals by transkript magazine. Read transkript's article here: Full article (pp. 5 - 6)
Our value contributions to Buy- and & Sell-side Advisory includes:
Our Approach to Sell-side Advisory
CONNECT WITH USinfo@bgmassociates.com
+49 30 8148 7127 |
VISIT OUR OFFICEWinkler Straße 11
14193 Berlin – Germany |
|